Major Rating Factors:
Poor long-term capitalization index (1.7 on a scale of 0 to 10) based on fair current risk adjusted capital (moderate loss scenario). Weak overall results on stability tests (0.0) including weak results on operational trends and negative cash flow from operations for 2022. The largest net exposure for one risk is excessive at 39.3% of capital.
Other Rating Factors:
Good overall profitability index (5.9). Fair expense controls. Return on equity has been excellent over the last five years averaging 65.6%. Ample reserve history (9.9) that helps to protect the company against sharp claims increases. Excellent liquidity (7.3) with ample operational cash flow and liquid investments.
Stability Factors:
D - Limited diversification of general business, policy, and/or investment risk.
F - Negative cash flow.
T - Significant trends in critical asset, liability, income or expense items.
Principal Lines of Business:
Med mal (0.9%), other (99.1%)
Licensed in:
KY
Principal Investments:
Investment grade bonds (99.8%), cash (0.2%)